Jancy Johnson, PhD, specializes in translational research and clinical drug development focused on chronic degenerative diseases. They served as a Research Scientist at Exopharm from 2017 to 2022, where they contributed to the clinical development of a platelet-derived therapeutic and successfully facilitated the execution of clinical trials. Currently, Jancy is a Senior Scientist at Magellan Stem Cells and a University Tutor at Swinburne University, where they engage in teaching and community outreach. With a PhD in Pharmacology and Therapeutics from the University of Melbourne, Jancy is passionate about simplifying complex scientific ideas for broader audiences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices